| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| Gene symbol | FOLH1 | Synonyms | FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM, PSMA, mGCP | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p11.12 | dbXrefs | |
| Description | folate hydrolase 1 | ||||
| GTO ID | GTC3094 |
| Trial ID | NCT05437341 |
| Disease | Cancer Disease |
| Altered gene | PSMA|CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD70/PSMA T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | PSMA/CD70 Bi-specific CAR-T Cell Therapy |
| Year | 2022 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-22004 |
| Cohort 1 | |||||||||
|
|||||||||